| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Carcinogenesis |
Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6084
Human dihydrodiol dehydrogenase (DD) isoforms are aldo-keto reductases (AKRs) that activate polycyclic aromatic hydrocarbons (PAHs) by oxidizing trans-dihydrodiol proximate carcinogens to reactive and redox-active ortho-quinones. Of these, human AKR1C1 (DD1) and AKR1C2 (DD2) oxidize trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to the cytotoxic and genotoxic metabolite benzo[a]pyrene-7,8-dione (BPQ) with the highest catalytic efficiency. Exposure of HepG2 cells to a panel of inducers revealed that mRNA encoding one or more human AKR1C member(s) was induced (3- to 10-fold) by benzo[a]pyrene and other polycyclic aromatic compounds (bifunctional inducers), electrophilic Michael acceptors and phenolic antioxidants (monofunctional inducers), and reactive oxygen species (ROS). The induction of AKR1C mRNA by bifunctional inducers was delayed with respect to the induction of CYP1A1 mRNA, and AKR1C mRNA was not induced by the nonmetabolizable aryl hydrocarbon receptor ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). These data suggest that, in contrast to the CYPs, induction of AKR1C member(s) by PAHs and other bifunctional inducers is mediated indirectly via an antioxidant response element rather than a xenobiotic response element. Immunoblot and enzymatic assays confirmed that the increases in AKR1C mRNA were faithfully translated into functional AKR1C protein(s). The increased DD activity in HepG2 lysates was inhibited only by high concentrations of ursodeoxycholate, which suggested that AKR1C2 (DD2, bile-acid-binding protein) was not the isoform induced. RNase protection assays identified AKR1C1 (DD1) mRNA as the transcript which was up-regulated by mono- and bi-functional inducers and ROS in both human hepatoma (HepG2) and colon carcinoma (HT29) cells. BPQ, the electrophilic and redox-cycling product of the AKR1C1 reaction, also induced AKR1C1 expression. Thus, BPQ formation by AKR1C1 results in both a chemical (redox-cycling) and a genetic (AKR1C1 induction) amplification of ROS in PAH-exposed cells. Because ROS have been implicated in both tumor initiation and tumor promotion, the amplification of ROS by this pathway may play a significant role in PAH carcinogenesis.
This article has been cited by other articles:
|
|
 |
|
  T. M. Penning and C. Lerman Genomics of Smoking Exposure and Cessation: Lessons for Cancer Prevention and Treatment Cancer Prevention Research, July 1, 2008; 1(2): 80 - 83. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Lou, S. Du, Q. Ji, and A. Stolz Induction of AKR1C2 by Phase II Inducers: Identification of a Distal Consensus Antioxidant Response Element Regulated by NRF2 Mol. Pharmacol., May 1, 2006; 69(5): 1662 - 1672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Chanson, T. Sayd, E. Rock, C. Chambon, V. Sante-Lhoutellier, G. Potier de Courcy, and P. Brachet Proteomic Analysis Reveals Changes in the Liver Protein Pattern of Rats Exposed to Dietary Folate Deficiency J. Nutr., November 1, 2005; 135(11): 2524 - 2529. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Alkio, T. M. Tabuchi, X. Wang, and A. Colon-Carmona Stress responses to polycyclic aromatic hydrocarbons in Arabidopsis include growth inhibition and hypersensitive response-like symptoms J. Exp. Bot., November 1, 2005; 56(421): 2983 - 2994. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Gao, A. A. Voss, I. N. Pessah, F. T. Lauer, T. M. Penning, and S. W. Burchiel Ryanodine Receptor-Mediated Rapid Increase in Intracellular Calcium Induced by 7,8-Benzo(a)Pyrene Quinone in Human and Murine Leukocytes Toxicol. Sci., October 1, 2005; 87(2): 419 - 426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. W. P. Devling, C. D. Lindsay, L. I. McLellan, M. McMahon, and J. D. Hayes Utility of siRNA against Keap1 as a strategy to stimulate a cancer chemopreventive phenotype PNAS, May 17, 2005; 102(20): 7280 - 7285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Penning AKR1B10: A New Diagnostic Marker of Non-Small Cell Lung Carcinoma in Smokers Clin. Cancer Res., March 1, 2005; 11(5): 1687 - 1690. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Mahadevan, C. Keshava, T. Musafia-Jeknic, A. Pecaj, A. Weston, and W. M. Baird Altered Gene Expression Patterns in MCF-7 Cells Induced by the Urban Dust Particulate Complex Mixture Standard Reference Material 1649a Cancer Res., February 15, 2005; 65(4): 1251 - 1258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Ji, C. Aoyama, Y.-D. Nien, P. I. Liu, P. K. Chen, L. Chang, F. Z. Stanczyk, and A. Stolz Selective Loss of AKR1C1 and AKR1C2 in Breast Cancer and Their Potential Effect on Progesterone Signaling Cancer Res., October 15, 2004; 64(20): 7610 - 7617. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Leverrier, D. Dimova, V. Pichereau, Y. Auffray, P. Boyaval, and G. Jan Susceptibility and Adaptive Response to Bile Salts in Propionibacterium freudenreichii: Physiological and Proteomic Analysis Appl. Envir. Microbiol., July 1, 2003; 69(7): 3809 - 3818. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Cancino-Badias, R.E. Reyes, R. Nosti, I. Perez, V. Dorado, S. Caballero, A. Soria, R. Camacho-Carranza, D. Escobar, and J.J. Espinosa-Aguirre Modulation of rat liver citochrome P450 by protein restriction assessed by biochemical and bacterial mutagenicity methods Mutagenesis, January 1, 2003; 18(1): 95 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. T. Palackal, S. H. Lee, R. G. Harvey, I. A. Blair, and T. M. Penning Activation of Polycyclic Aromatic Hydrocarbon trans-Dihydrodiol Proximate Carcinogens by Human Aldo-keto Reductase (AKR1C) Enzymes and Their Functional Overexpression in Human Lung Carcinoma (A549) Cells J. Biol. Chem., June 28, 2002; 277(27): 24799 - 24808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Blaha, P. Kapplova, J. Vondracek, B. Upham, and M. Machala Inhibition of Gap-Junctional Intercellular Communication by Environmentally Occurring Polycyclic Aromatic Hydrocarbons Toxicol. Sci., January 1, 2002; 65(1): 43 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Bonnesen, I. M. Eggleston, and J. D. Hayes Dietary Indoles and Isothiocyanates That Are Generated from Cruciferous Vegetables Can Both Stimulate Apoptosis and Confer Protection against DNA Damage in Human Colon Cell Lines Cancer Res., August 1, 2001; 61(16): 6120 - 6130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N.-Y. Hsu, H.-C. Ho, K.-C. Chow, T.-Y. Lin, C.-S. Shih, L.-S. Wang, and C.-M. Tsai Overexpression of Dihydrodiol Dehydrogenase as a Prognostic Marker of Non-Small Cell Lung Cancer Cancer Res., March 1, 2001; 61(6): 2727 - 2731. [Abstract] [Full Text]
|
|
|
|
|
|
I. N. Pessah, C. Beltzner, S. W. Burchiel, G. Sridhar, T. Penning, and W. Feng A Bioactive Metabolite of Benzo[a]pyrene, Benzo[a]pyrene-7,8-dione, Selectively Alters Microsomal Ca2+ Transport and Ryanodine Receptor Function Mol. Pharmacol., March 1, 2001; 59(3): 506 - 513. [Abstract] [Full Text]
|
|
|
|
 |
|
 I. Dufort, F. Labrie, and V. Luu-The Human Types 1 and 3 3{{alpha}}-Hydroxysteroid Dehydrogenases: Differential Lability and Tissue Distribution J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 841 - 846. [Abstract] [Full Text]
|
|
|
|
|
|
M. E. Burczynski and T. M. Penning Genotoxic Polycyclic Aromatic Hydrocarbon ortho-Quinones Generated by Aldo-Keto Reductases Induce CYP1A1 via Nuclear Translocation of the Aryl Hydrocarbon Receptor Cancer Res., February 1, 2000; 60(4): 908 - 915. [Abstract] [Full Text]
|
|
|
|
|
|
V. P. Kelly, E. M. Ellis, M. M. Manson, S. A. Chanas, G. J. Moffat, R. McLeod, D. J. Judah, G. E. Neal, and J. D. Hayes Chemoprevention of Aflatoxin B1 Hepatocarcinogenesis by Coumarin, a Natural Benzopyrone That Is a Potent Inducer of Aflatoxin B1-Aldehyde Reductase, the Glutathione S-Transferase A5 and P1 Subunits, and NAD(P)H:Quinone Oxidoreductase in Rat Liver Cancer Res., February 1, 2000; 60(4): 957 - 969. [Abstract] [Full Text]
|
|
|
|
 |
|
 C.-F. Hung and T. M. Penning Members of the Nuclear Factor 1 Transcription Factor Family Regulate Rat 3{alpha}-Hydroxysteroid/Dihydrodiol Dehydrogenase (3{alpha}-HSD/DD AKR1C9) Gene Expression: A Member of the Aldo-keto Reductase Superfamily Mol. Endocrinol., October 1, 1999; 13(10): 1704 - 1717. [Abstract] [Full Text]
|
|
|
|
|
|
M. E. Burczynski, G. R. Sridhar, N. T. Palackal, and T. M. Penning The Reactive Oxygen Species- and Michael Acceptor-inducible Human Aldo-Keto Reductase AKR1C1 Reduces the alpha ,beta -Unsaturated Aldehyde 4-Hydroxy-2-nonenal to 1,4-Dihydroxy-2-nonene J. Biol. Chem., January 19, 2001; 276(4): 2890 - 2897. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
